Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
paracetamol + morphine-Procare Riaya Hospital-postoperative pain refers to a clinical research study (NCT01366313) conducted at Procare Riaya Hospital to evaluate the median effective dose (ED50) and analgesic interaction of intravenous paracetamol and morphine. Paracetamol is a non-opioid analgesic that primarily works by inhibiting prostaglandin synthesis in the central nervous system, while morphine is a potent opioid analgesic that acts as an agonist at mu-opioid receptors. The study aimed to determine if the combination provides additive or synergistic effects for managing postoperative pain in patients undergoing moderately painful procedures like inguinal hernia repair or appendectomy. Results indicated an additive interaction, suggesting that the combination can effectively manage pain while potentially reducing the required dose of each individual component.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on paracetamol + morphine.